225 related articles for article (PubMed ID: 26639824)
21. New players in the fatty acyl ethanolamide metabolism.
Rahman IA; Tsuboi K; Uyama T; Ueda N
Pharmacol Res; 2014 Aug; 86():1-10. PubMed ID: 24747663
[TBL] [Abstract][Full Text] [Related]
22. Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation.
Impellizzeri D; Di Paola R; Cordaro M; Gugliandolo E; Casili G; Morittu VM; Britti D; Esposito E; Cuzzocrea S
Biochem Pharmacol; 2016 Nov; 119():27-41. PubMed ID: 27599446
[TBL] [Abstract][Full Text] [Related]
23. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
[TBL] [Abstract][Full Text] [Related]
24. Measurement of palmitoylethanolamide and other N-acylethanolamines during physiological and pathological conditions.
Balvers MG; Verhoeckx KC; Meijerink J; Wortelboer HM; Witkamp RF
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):23-33. PubMed ID: 23394528
[TBL] [Abstract][Full Text] [Related]
25. Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats.
; De Filippis D; D'Amico A; Cipriano M; Petrosino S; Orlando P; Di Marzo V; Iuvone T
Pharmacol Res; 2010 Apr; 61(4):321-8. PubMed ID: 19931394
[TBL] [Abstract][Full Text] [Related]
26. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
[TBL] [Abstract][Full Text] [Related]
27.
Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
[No Abstract] [Full Text] [Related]
28. Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action.
Del Re A; Palenca I; Seguella L; Pesce M; Corpetti C; Steardo L; Rurgo S; Sarnelli G; Esposito G
Metabolites; 2022 May; 12(5):. PubMed ID: 35629962
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide.
D'Aloia A; Arrigoni F; Tisi R; Palmioli A; Ceriani M; Artusa V; Airoldi C; Zampella G; Costa B; Cipolla L
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260658
[TBL] [Abstract][Full Text] [Related]
31. Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.
Esposito E; Cuzzocrea S
Mini Rev Med Chem; 2013 Feb; 13(2):237-55. PubMed ID: 22697514
[TBL] [Abstract][Full Text] [Related]
32. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
Jacobsson SO; Fowler CJ
Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
[TBL] [Abstract][Full Text] [Related]
33. The palmitoylethanolamide family: a new class of anti-inflammatory agents?
Lambert DM; Vandevoorde S; Jonsson KO; Fowler CJ
Curr Med Chem; 2002 Mar; 9(6):663-74. PubMed ID: 11945130
[TBL] [Abstract][Full Text] [Related]
34. Ramulus Cinnamomi essential oil exerts an anti-inflammatory effect on RAW264.7 cells through N-acylethanolamine acid amidase inhibition.
Jia W; He X; Jin W; Gu J; Yu S; He J; Yi Z; Cai B; Gao H; Yang L
J Ethnopharmacol; 2023 Dec; 317():116747. PubMed ID: 37311500
[TBL] [Abstract][Full Text] [Related]
35. Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture model.
Abramo F; Lazzarini G; Pirone A; Lenzi C; Albertini S; Della Valle MF; Schievano C; Vannozzi I; Miragliotta V
Vet Dermatol; 2017 Oct; 28(5):456-e104. PubMed ID: 28585337
[TBL] [Abstract][Full Text] [Related]
36. Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs.
Cerrato S; Brazis P; Della Valle MF; Miolo A; Petrosino S; Di Marzo V; Puigdemont A
Vet J; 2012 Mar; 191(3):377-82. PubMed ID: 21601500
[TBL] [Abstract][Full Text] [Related]
37. Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.
Alhouayek M; Rankin L; Gouveia-Figueira S; Fowler CJ
Br J Pharmacol; 2019 May; 176(10):1470-1480. PubMed ID: 29313885
[TBL] [Abstract][Full Text] [Related]
38. The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis.
Sasso O; Summa M; Armirotti A; Pontis S; De Mei C; Piomelli D
J Invest Dermatol; 2018 Mar; 138(3):562-569. PubMed ID: 29054595
[TBL] [Abstract][Full Text] [Related]
39. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Ueda N; Tsuboi K; Uyama T
Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
[TBL] [Abstract][Full Text] [Related]
40. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
